SHAREHOLDER SUPPORT AGREEMENTShareholder Support Agreement • December 6th, 2018 • OncoMed Pharmaceuticals Inc • Pharmaceutical preparations • New York
This SUPPORT AGREEMENT (this “Agreement”), dated as of December 5, 2018, is made by and between OncoMed Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and Invesco Asset Management Limited of Perpetual Park, Perpetual Park Drive, Henley-on-Thames, Oxfordshire, RG9 1HH, United Kingdom, a private company limited by shares with company registration number 00 949417 and registered in England and Wales (“Shareholder”), acting as agent for and on behalf of Invesco Income Fund (“Fund”).
FORM OF SHAREHOLDER SUPPORT AGREEMENTForm of Shareholder Support Agreement • December 6th, 2018 • OncoMed Pharmaceuticals Inc • Pharmaceutical preparations • New York
This SUPPORT AGREEMENT (this “Agreement”), dated as of December 5, 2018, is made by and between OncoMed Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and [insert name of shareholder] (“Shareholder”).
FORM OF STOCKHOLDER SUPPORT AGREEMENTForm of Stockholder Support Agreement • December 6th, 2018 • OncoMed Pharmaceuticals Inc • Pharmaceutical preparations • New York
This SUPPORT AGREEMENT (this “Agreement”), dated as of December 5, 2018, is made by and between Mereo BioPharma Group plc, a public limited company incorporated under the laws of England and Wales (“Milan”), and [insert name of stockholder] (“Stockholder”).
AGREEMENT AND PLAN OF MERGER AND REORGANIZATION among: MEREO BIOPHARMA GROUP PLC, a public limited company incorporated under the laws of England and Wales; MEREO US HOLDINGS INC., a Delaware corporation; MEREO MERGERCO ONE INC., a Delaware...Agreement and Plan of Merger and Reorganization • December 6th, 2018 • OncoMed Pharmaceuticals Inc • Pharmaceutical preparations • New York
THIS AGREEMENT AND PLAN OF MERGER AND REORGANIZATION (this “Agreement”) is made and entered into as of December 5, 2018, by and among MEREO BIOPHARMA GROUP PLC, a public limited company incorporated under the laws of England and Wales (“Milan”), MEREO US HOLDINGS INC., a Delaware corporation and wholly-owned subsidiary of Milan (“HoldCo”), MEREO MERGERCO ONE INC., a Delaware corporation and wholly-owned subsidiary of HoldCo (“Merger Sub”), and ONCOMED PHARMACEUTICALS, INC., a Delaware corporation (the “Company”). Certain capitalized terms used in this Agreement are defined in Exhibit A.
